Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charu Kothari

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
NAR Cancer|August 23, 2023
The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitorsAdèle Beneyton, Louis Nonfoux, Jean-Philippe Gagné, et al.
Cancer Research|October 30, 2016
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 AxisNandini Verma, Anna-Katharina Müller, Charu Kothari, et al.
Cancer Research|January 17, 2020
Correction: Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 AxisNandini Verma, Anna-Katharina Müller, Charu Kothari, et al.
Nucleic Acids Research|October 12, 2023
ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistanceJulia O'Sullivan, Charu Kothari, Marie-Christine Caron, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
NAR Cancer|August 23, 2023
The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitorsAdèle Beneyton, Louis Nonfoux, Jean-Philippe Gagné, et al.
Cancer Research|October 30, 2016
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 AxisNandini Verma, Anna-Katharina Müller, Charu Kothari, et al.
Cancer Research|January 17, 2020
Correction: Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 AxisNandini Verma, Anna-Katharina Müller, Charu Kothari, et al.
Nucleic Acids Research|October 12, 2023
ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistanceJulia O'Sullivan, Charu Kothari, Marie-Christine Caron, et al.
Pageof 2